Pune: According to the World Health Organization’s ‘The World Health Statistics 2012’ report, there will be 70 million diabetic patients in India by 2025. Estimates have shown that up to 25 percent of patients with diabetes develop a foot ulcer, and approximately 56 percent of diabetic ulcerations will become infected and 20 percent of such patients will have to undergo lower limb amputations. Therefore, there is an increasing need for a low cost, comprehensive treatment of diabetic ulcerations, which cannot be treated using normal wound treatments such as bandaging. India is a diabetic capital of the world and diabetic foot ulcer is going to be a major problem to address in a country like India.
Now the Pune (India) based startup, WeInnovate Biosolutions has come up with an answer. It is developing a novel formulation which can be used in Gel form or with wound closure materials (such as bandages and sutures) for rapid wound healing. HEALRAP, the company’s first registered innovative product, is a novel organic and inorganic nano-formulation that demonstrates three-way action:
So, how is the product unique?
HEALRAP helps subside the inflammation, provides antimicrobial action and promotes cell proliferation for rapid wound healing. The most innovative aspect of the formulation is that it targets the root cause that makes a wound critical, helping restore blood, oxygen, and nutrition flow to the wound ensuring rapid healing. Another unique selling point of this formulation is that it is inorganic in nature, which means that the problem of antibiotic resistance is circumvented. The R&D product has reached to pre-clinical investigative studies.
“This problem has not been looked on with attention and we believe this problem can be solved with strategically devising the treatment options,” mentioned Mr Milind Chaudhari, who is the primary founder and Chief Executive Officer of the WeInnovate Biosolutions.
The BIRAC according to me is the best organization to catalyse the start-up activity in India. We were a group of scientists and hoping to do something to make a change but the decision to form a company rolled in because BIRAC showed the initial trust on us.
Milind Chaudhari, CEO, WeInnovate Biosolutions